Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CYTKCYTK
Showing 8 of 30 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in CYTOKINETICS INC

CITADEL ADVISORS LLC holds 1.1M shares of CYTK (CYTOKINETICS INC), worth $72.5M as of 2026-Q1. The position was decreased (-5.4% shares). CYTK represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$72.5M

Current Shares

1.1M

Total Value Change

+$26M

Total Shares Change

+240,885

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
1.1M
-5.4%
$72.5M0.0%$60.72
0
2025-Q4
Decreased
1.2M
-16.1%
$73.9M0.0%$61.37
0
2025-Q3
Increased
1.4M
+6.7%
$76.2M0.0%$53.89
32
2025-Q2
Increased
1.3M
+12.9%
$42.9M0.0%$33.16
33
2025-Q1
Decreased
1.2M
-16.1%
$46.2M0.0%$43.19
0
2024-Q4
Increased
1.4M
+46.4%
$64.5M0.0%$47.15
40
2024-Q3
Increased
937,191
+9.1%
$49.5M0.0%$52.34
32
2024-Q2
Increased
858,973
+53.1%
$46.5M0.0%$54.18
41

Other major holders of CYTK: BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used